Eisai and Merck & Co., Inc., Rahway, NJ, USA Provide Update on Phase 3 LEAP-002 Trial
TOKYO and RAHWAY, N.J., A […]
TOKYO and RAHWAY, N.J., A […]
Seoul, Korea,June8, 2022- […]
SHANGHAI, CHINA, Jun 7, 2 […]
TOKYO, Jun 6, 2022 – […]
TOKYO, May 27, 2022 ̵ […]
TOKYO, Mar 28, 2022 ̵ […]
Tokyo and Salt Lake City, […]
HONG KONG, Mar 14, 2022 & […]
TOKYO, Mar 7, 2022 – […]
TOKYO and KENILWORTH, N.J […]
TOKYO, Jan 17, 2022 ̵ […]
TOKYO, Dec 21, 2021 ̵ […]
TOKYO, Nov 30, 2021 ̵ […]
Strasbourg, France & […]
MENLO PARK, CA and HELSIN […]
TOKYO, Sep 27, 2021 ̵ […]
SHANGHAI, Sep 26, 2021 &# […]
TOKYO, Sep 14, 2021 ̵ […]
NEW JERSEY, the U.S. and […]
TOKYO, Aug 2, 2021 – […]
TOKYO and KENILWORTH, N.J […]
TOKYO, Jul 19, 2021 ̵ […]
Cambridge, MA, Jun 8, 202 […]
TOKYO, Jun 8, 2021 – […]
TOKYO, May 20, 2021 ̵ […]
Tokyo, May 19, 2021 ̵ […]
SHANGHAI, CHINA, Apr 23, […]